Investing

Buy Rating Affirmed for VYNE Therapeutics Amidst Favorable IND Clearance and Promising VYN202 Development

LifeSci Capital analyst Rami Katkhuda has maintained their bullish stance on VYNE stock, giving a Buy rating today.Rami Katkhuda has given his Buy …

Crypto analysts predict ‘landslide’ win for Trump, project effects on markets

Cryptocurrency experts predicted a Donald Trump presidential victory this year and outlined the political impact on digital assets. As the political …

Citigroup CEO Jane Fraser says low-income consumers have turned far more cautious with spending

Citigroup CEO Jane Fraser says low-income consumers have turned far more cautious with spending

Citigroup CEO Jane Fraser said Monday that consumer behavior has diverged as inflation for goods and services makes life harder for many …

What’s making BTC traders excited today?

With Bitcoin prices steadying, traders opt to reduce their leverage utilization.

Quest Diagnostics To Acquire PathAI Diagnostics To Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI

SECAUCUS, N.J. and BOSTON, May 6, 2024 /3BL/ – Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global …

ALL NEWS